Ratings by Jefferies
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/1/2026 | Akash Tewari | Latigo Biotherapeutics | LTGO | New Coverage | Buy (N/A) |
50.00 (N/A) |
22.02 (22.86) |
3.81% | Details |
| 9/1/2026 | Julian Dumoulin-Smith | Sempra Energy | SRE | Upgrade | Buy (Hold) |
97.00 (101.00) |
81.70 (83.29) |
1.95% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 31,731 more... | |||||||||
